BCPC · Categories · Form 4
BCPC - SEC Form 4 insider transactions
Balchem Corporation (BCPC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for BCPC
- SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 1,775 shares and covered exercise/tax liability with 814 shares, increasing direct ownership by 10% to 10,149 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,299 shares and covered exercise/tax liability with 1,201 shares, increasing direct ownership by 30% to 9,073 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Chairman, President & CEO Harris Theodore L was granted 25,641 shares and covered exercise/tax liability with 10,202 shares, increasing direct ownership by 20% to 91,373 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP and Chief R&D Officer Graham George was granted 700 shares, increasing direct ownership by 28% to 3,200 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- VP & Chief Accounting Officer Backus William A. was granted 2,154 shares and covered exercise/tax liability with 935 shares, increasing direct ownership by 22% to 6,736 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP/GM, Human Nutri. & Health Boned Frederic was granted 5,117 shares and covered exercise/tax liability with 1,354 shares, increasing direct ownership by 72% to 8,978 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP & Chief HR Officer Tignor Michael Brent was granted 3,129 shares and covered exercise/tax liability with 1,156 shares, increasing direct ownership by 23% to 10,723 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP, CLO, & Secretary Miyata Hatsuki was granted 3,957 shares and covered exercise/tax liability with 1,058 shares, increasing direct ownership by 50% to 8,745 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP & Chief Financial Officer Bengtsson Carl Martin was granted 8,328 shares and covered exercise/tax liability with 2,718 shares, increasing direct ownership by 25% to 27,926 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Fischer David B was granted 870 shares, increasing direct ownership by 11% to 8,859 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Vicente Monica was granted 870 shares, increasing direct ownership by 57% to 2,390 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Rigaud Olivier was granted 870 shares, increasing direct ownership by 57% to 2,390 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Knutson Daniel E was granted 870 shares, increasing direct ownership by 14% to 6,899 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Fish Kathleen B was granted 870 shares, increasing direct ownership by 34% to 3,429 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Wineinger Matthew David was granted 870 shares, increasing direct ownership by 12% to 8,012 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- VP & Chief Accounting Officer Backus William A. covered exercise/tax liability with 322 shares, decreasing direct ownership by 6% to 5,517 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP, CLO, & Secretary Miyata Hatsuki covered exercise/tax liability with 343 shares, decreasing direct ownership by 6% to 5,846 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP and GM, Specialty Products Van Gunsteren Job Leonard covered exercise/tax liability with 258 shares, decreasing direct ownership by 3% to 9,188 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- VP & Chief Accounting Officer Backus William A. covered exercise/tax liability with 383 shares, decreasing direct ownership by 6% to 5,839 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Chairman, President & CEO Harris Theodore L covered exercise/tax liability with 3,225 shares, decreasing direct ownership by 4% to 75,934 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP & Chief Financial Officer Bengtsson Carl Martin covered exercise/tax liability with 863 shares, decreasing direct ownership by 4% to 22,316 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP/GM, Human Nutri. & Health Boned Frederic covered exercise/tax liability with 430 shares, decreasing direct ownership by 8% to 5,215 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP & Chief HR Officer Tignor Michael Brent covered exercise/tax liability with 373 shares, decreasing direct ownership by 4% to 8,750 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP Chief Supply Chain Officer Reid Martin Luther covered exercise/tax liability with 416 shares, decreasing direct ownership by 6% to 6,975 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Fischer David B exercised 6,000 shares at a strike of $78.72 and sold $1,231,748 worth of shares (8,000 units at $153.97), decreasing direct ownership by 20% to 7,989 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP and GM, Specialty Products Van Gunsteren Job Leonard exercised 6,000 shares at a strike of $60.85 and sold $919,723 worth of shares (6,000 units at $153.29) (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP Chief Supply Chain Officer Reid Martin Luther sold $185,328 worth of shares (1,200 units at $154.44), decreasing direct ownership by 14% to 7,391 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP/GM, Human Nutri. & Health Boned Frederic covered exercise/tax liability with 1,085 shares, decreasing direct ownership by 16% to 5,645 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP and Chief R&D Officer Graham George was granted 2,500 shares (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP, CLO, & Secretary Miyata Hatsuki covered exercise/tax liability with 483 shares, decreasing direct ownership by 7% to 6,189 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Amendment: SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 2,128 shares and covered exercise/tax liability with 964 shares, increasing direct ownership by 14% to 9,446 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: SVP & Chief HR Officer Tignor Michael Brent was granted 3,497 shares and covered exercise/tax liability with 1,156 shares, increasing direct ownership by 35% to 9,123 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,889 shares and covered exercise/tax liability with 1,059 shares, increasing direct ownership by 49% to 8,591 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: VP & Chief Accounting Officer Backus William A. was granted 2,617 shares and covered exercise/tax liability with 1,073 shares, increasing direct ownership by 33% to 6,222 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: EVP, CLO, & Secretary Miyata Hatsuki was granted 1,840 shares, increasing direct ownership by 38% to 6,672 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: EVP & Chief Financial Officer Bengtsson Carl Martin was granted 7,792 shares and covered exercise/tax liability with 2,781 shares, increasing direct ownership by 28% to 23,179 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: Chairman, President & CEO Harris Theodore L was granted 28,964 shares and covered exercise/tax liability with 11,442 shares, increasing direct ownership by 28% to 79,159 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: SVP/GM, Human Nutri. & Health Boned Frederic was granted 1,580 shares, increasing direct ownership by 31% to 6,730 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: Director Rigaud Olivier was granted 980 shares, increasing direct ownership by 181% to 1,520 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: Director Fish Kathleen B was granted 980 shares, increasing direct ownership by 62% to 2,559 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- Amendment: Director Knutson Daniel E was granted 980 shares, increasing direct ownership by 19% to 6,029 units (SEC Form 4)4/A - BALCHEM CORP (0000009326) (Issuer)
- SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 2,128 shares and covered exercise/tax liability with 964 shares, increasing direct ownership by 14% to 9,446 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,889 shares and covered exercise/tax liability with 1,059 shares, increasing direct ownership by 49% to 8,591 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP & Chief HR Officer Tignor Michael Brent was granted 3,497 shares and covered exercise/tax liability with 1,156 shares, increasing direct ownership by 35% to 9,123 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Chairman, President & CEO Harris Theodore L was granted 28,964 shares and covered exercise/tax liability with 11,442 shares, increasing direct ownership by 28% to 79,159 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP, Gen. Counsel & Secretary Miyata Hatsuki was granted 1,840 shares, increasing direct ownership by 38% to 6,672 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP & Chief Technology Officer Sestrick Michael Robert was granted 2,016 shares and covered exercise/tax liability with 1,045 shares, increasing direct ownership by 26% to 4,762 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP & Chief Financial Officer Bengtsson Carl Martin was granted 7,792 shares and covered exercise/tax liability with 2,781 shares, increasing direct ownership by 28% to 23,179 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP/GM, Human Nutri. & Health Boned Frederic was granted 1,580 shares, increasing direct ownership by 31% to 6,730 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- VP & Chief Accounting Officer Backus William A. covered exercise/tax liability with 1,073 shares and was granted 2,617 shares, increasing direct ownership by 33% to 6,222 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Vicente Monica was granted 980 shares, increasing direct ownership by 181% to 1,520 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Wineinger Matthew David was granted 980 shares, increasing direct ownership by 16% to 7,142 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Knutson Daniel E was granted 980 shares, increasing direct ownership by 19% to 6,029 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Fish Kathleen B was granted 980 shares, increasing direct ownership by 62% to 2,559 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Fischer David B was granted 980 shares, increasing direct ownership by 11% to 9,989 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Director Rigaud Olivier was granted 980 shares, increasing direct ownership by 181% to 1,520 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- VP & Chief Accounting Officer Backus William A. covered exercise/tax liability with 310 shares, decreasing direct ownership by 6% to 4,678 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- Chairman, President & CEO Harris Theodore L covered exercise/tax liability with 3,071 shares, decreasing direct ownership by 5% to 61,637 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- SVP and GM, Specialty Products Van Gunsteren Job Leonard covered exercise/tax liability with 258 shares, decreasing direct ownership by 3% to 8,282 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- EVP & Chief Financial Officer Bengtsson Carl Martin covered exercise/tax liability with 777 shares, decreasing direct ownership by 4% to 18,168 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)